AAP Health Supervision for Children with Fragile X Syndrome Flashcards
What is the genetic inheritance for Fragile X?
FMR1 gene with trinucleotide repeat (CGG)
>200 full mutation
55-200 premutation
45-54 intermediate or “gray-zone” alleles
5-40 normal
What is the clinical phenotype for males with fragile X?
- Developmental delay
- Mental retardation
- Prominent forehead
- Long, narrow face
- Prominent jaw
- Protruberant ears
- High arched palate
- Cleft palate
- Dental crowding
- Malocclusion
- Strabismus (23-50% refractive errors)
- Nystagmus
- Ptosis
- Macro-orchidism ~80% adolescents
- Connective tissue dysplasia:
a) soft velvet-like skin
b) joint hypermobility esp. fingers
c) pes planus
d) congenital hip dislocation
e) scoliosis
f) clubfoot
g) mitral valve prolapse in adults - GER (1/3 of infants)
- Chronic otitis media 60-80%
- Recurrent otitis media 23%
- Seizures ~13-18%
- Relative macrocephaly
- Tall stature in childhood
- Subgroup “Prader-Willi syndrome clinical phenotype”: extreme obesity, short stature, stubby hands and feet, diffuse hyperpigmentation
- Mental retardation
- Cognitive deficits
- Language delay
- ADHD 80%
- Anxiety incld. OCD
- Emotional lability
- Aggressive and self-injurious behaviors
- Hypersensitivity to sensory stimuli
- Autism features, 30% with full mutation have
- Premature ovarian insufficiency in females with premutation
- FXTAS - ataxia in 50s of males with premutation
Who should have molecular genetic testing by PCR and/or southern blot analysis for FMR1?
- Patient with family history of fragile X syndrome
- Males and females >50yo with progressive cerebellar ataxia and intention tremor
- Patients with developmental delay, intellectual disability of unknown etiology or autism
- Females with premature ovarian insufficiency (POI)
What should occur during the prenatal visit for Fragile X syndrome?
- Review the diagnostic studies that led to establishment of the diagnosis
- Explain the clinical manifestations, the variability seen in fragile X syndrome and the long term prognosis
- Review the clinical manifestations, the variability seen in fragile X syndrome, and the long-term prognosis
- Review currently available treatments and interventions
- Explore options (termination, rearing at home, foster care, adoption)
What are the health supervision guidelines for newborns with Fragile X (birth to 1mo)?
- Examine the neonate for any orthopedic abnormalities, esp. congenital hip dysplasia and clubfoot
- Review molecular testing with the family
- Review clinical manifestations
- Monitor OFC and monitor head growth velocity
- Monitor for feeding difficulties and symptoms of GER
What anticipatory guidance is recommended for newborns with Fragile X (birth to 1mo)?
- Review the support groups and services available
- Discuss resources available for personal support
- Discuss how and what to tell family members and friends about the neonate’s condition
- Review the recurrence risk for subsequent pregnancies
- Discuss options for family planning and genetic counselling
- Review the family history for other family members at risk of Fragile X
What are the health supervision guidelines during infancy for Fragile X (1mo to 1yo)?
- Monitor for hypotonia and mild motor delay
- Monitor for irritability, which is usu. secondary to sensory problems incld. tactile hypersensitvity
- Monitor for feeding problems, esp. GER
What anticipatory guidance are recommended for infants (1mo to 1yo) with Fragile X?
- Monitor growth parameters closely
- Pursue diagnostic evaluation if feeding problems are severe
- Review available resources to provide the infant with early-intervention services
What are the health supervision guidelines for Fragile X in early childhood (1-5yo)?
- Ophthalmology evaluation for strabismus and refractive errors
- Evaluate child for orthopedic problems related to connective tissue dysplasia esp. pes planus (80% affected children), hypermobile joints, and scoliosis
- Treat pronated feet require treatment with orthotics if gait disturbance exists
- Examine the child for inguinal hernias esp. @1-3yo
- Assess the child’s history for seizures or staring episodes and obtain an EEG if clinically indicated
- Monitor the child for recurrent otitis media (60-80%) could be associated with conductive hearing loss, also for recurrent sinusitis (23%)
- Monitor child’s audiologic status yearly
- Monitor language closely
- OT evaluation as indicated
- IQ testing
- Requires early developmental services
- Monitor child’s emotional and behavioral status closely and provide interventions as needed
- Psychopharmacologic interventions can be helpful
- consider stimulant medication, clonidine, guanfacine, SSRI, atypical antipsychotics - Monitor linear growth (should be normal)
- Monitor for facial changes and regular dental evaluations recommended
- Monitor OSA
- Delayed toilet training is common and likely to reflect the child’s cognitive status
What anticipatory guidance should be provided for patients with Fragile X in early childhood (1-5yo)?
- Determine if behaviors such as hyperactivity, aggression, self-injury, and tantrums warrant medical management
- Appropriate evaluation and treatment is indicated when suspicion of seizure if present
- Monitor for murmurs, clicks, and BP and provide medical treatment as indicated
- Delays in toilet-training help with behavioral interventions
- Review the future reproductive plans for the parents and discuss recurrence risk and family planning options when indicated
What are the health supervision guidelines for Fragile X in late childhood (5-12yo)?
- Measure testicular volume with orchidiometer and assess for presence of hernia
- Monitor for precocious puberty in girls with full mutation
- Monitor for cognitive, speech, language, and motor needs and modifications or further evaluation are indicated
4, Monitor ADHD and address behaviorally and/or in combination with medication management - Monitor for anxiety, esp. OCD and appropriate management
- Monitor for cognitive impairments and provide appropriate services
- Enuresis is common –> manage appropriately
- Monitor for scoliosis due to connective tissue dysplasia (~20%)
What are the health supervision guidelines for Fragile X in adolescent to early adulthood (13-21yo)?
- Attentional problems and impulsivity frequently persist and may continue to need to be addressed behaviorally and medically
- Assess adolescents for seizures esp. atypical
- Reassure that macro-orchidism will persist but are fertile
- Monitor for growth, psychosocial development, physical sexual development, and fertility
- Discuss genetic mechanisms responsible for fragile X syndrome
- Determine if behavioral problems continue to represent a concern, and pursue behavioral/psychological intervention if indicated
- Discuss the availability and need for vocational training and group home placement if appropriate
- Monitor for a cardiac murmur or click, if either is heard pursue a cardiology evaluation
- Facilitate transition to adult medical care as appropriate or desired
What are the health supervision guidelines for Fragile X in adulthood?
- Mitral valve prolapse (~50% affected adults) with mild aortic root dilatation
- Monitor for hypertension
- Greater risk of emotional problems in affected females, esp. at times of hormonal changes or estrogen deficiency, such as menopause, the postpartum period and during menstrual periods
- Genetic counseling and review for risks of transmission
- Risk of FXTAS >50yo in men>women with premutation